This study looks at bladder cancer patients who have severe side effects from standard BCG therapy. It tests whether reducing the time the drug stays in the bladder (dwell-time) can lessen those side effects and help patients complete their full treatment course. About 314 partic…
Phase: PHASE4 • Sponsor: Jørgen Bjerggaard Jensen • Aim: Symptom relief
Last updated May 02, 2026 00:59 UTC